🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with numerous of members share comparison images, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering substances of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the service has taken down violative content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these communities, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram stated it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously seen patients harmed by personal administration from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to potentially serious health risks”.